To the Editor:
Nextgen sequencing technologies have enabled noninvasive prenatal testing of fetal aneuploidies by shotgun sequencing of maternal plasma DNA during pregnancy (1 ) . A statistically significant change (e.g., using z-score statistics) in the number of reads mapped to a chromosome of interest (such as chromosome 21) is used to identify fetal aneuploidy. The accuracy of the test is largely dependent on 2 factors: the variability (SD) of the percentage of reads mapped to the chromosome of interest among euploidy samples and the absolute difference between the sample being tested and the mean of the euploidy samples.
We speculated that the PCR enrichment step in the library preparation before cluster generation and sequencing contributes to the variation in chromosome dosage determination. Additionally, with 3 ng of DNA (typically obtainable from about 2 mL of maternal plasma) at an average size of 150 bp per DNA fragment, around 20 billion DNA fragments were available for sequencing, suggesting PCR amplification may not be necessary.
We thus modified the current protocol for library preparation from maternal plasma DNA by removing the PCR enrichment step. Maternal plasma samples of about 2.5-3.2 mL were obtained with informed consent. DNA preparation and sequencing library preparation were performed as previously described (2 ), up to the step for adaptor ligation and purification. The purified ligation products were then equally divided into 2 aliquots, one for the standard protocol with PCR enrichment (PCR ϩ ) 1 Preprocessing of the raw pairedend data from multiplexed sequencing was done using Illumina's CASAVA software (version 1.7), followed by alignment using bowtie-0.12.1 (3 ), with only 1 mismatch allowed. Paired-end reads were used to assess DNA insert size. Uniquely aligned single reads (read 1) were used for all other analyses.
The size distributions for the PCR ϩ and PCR Ϫ libraries were highly correlated, with the PCR ϩ libraries having a bias against longer fragments. Given that cell-free fetal DNA was generally smaller in size than maternal DNA, fetal DNA concentrations may have been overestimated by previous shotgun sequencing data (4 ).
To assess the variability in determining the chromosome dosages for both the PCR ϩ and PCR Ϫ protocols, we randomly sampled 2.5, 3, 3.5, 4, 4.5, and 5 million reads for each library for the PCR Ϫ and PCR ϩ protocols derived from 20 maternal plasma samples from euploidy pregnancies with gestational age at 14.9 (2.2) weeks (range, 12.1-19.4 weeks). The percentages of reads mapped to individual autosomes compared to total reads mapped to all autosomes were calculated. CVs for each autosome were then calculated. We repeated the random read selection 5 times at 2.5, 3, 3.5, 4, 4.5, and 5 million reads to further assess the variations due to read selections (error bar in Fig. 1 ).
As shown in Fig. 1 , the PCR Ϫ protocol reduced the CVs for most autosomes, regardless of the total read numbers. At 5 million total reads, all autosomes except chromosomes 2, 10, and 14 showed significant differences in CV between the PCR ϩ and PCR Ϫ protocols (P Ͻ 0.05, 2-sided t-test). As reported previously (4 ), autosomes with the lowest and highest GC contents showed the highest CVs. The CVs for chromosomes 13 and 18 were reduced by about 28% and 18%, respectively, which may be clinically useful because it is known that the detections of trisomy 18 and trisomy 13 are less accurate with the shotgun sequencing approach (5 ). Although the CV for chromosome 21 remained low, there was an apparent increase of 14% for the chromosome 21 CV. The actual impact on the detection of trisomy 21, trisomy 18, and trisomy 13 by the PCR Ϫ protocol needs to be further validated with a larger sample size.
As a proof-of-principal experiment, we also sequenced 3 trisomy 21 and 3 trisomy 18 maternal plasma samples with the PCR ϩ and PCR Ϫ protocols. The staff personnel for data analysis were blinded to the sample IDs. Sample IDs were unblinded only after all the chromosome mappings were finished. Correct calls were made for all samples with both the PCR ϩ and PCR Ϫ protocols, using a z-score cutoff of 3 (2).
In summary, we report here a simplified PCR Ϫ protocol for library preparation from maternal plasma DNA for the purpose of noninvasive prenatal testing of chromosomal aneuploidies. Our data suggest that this simplified protocol improves overall reproduc- ibility in quantifying chromosome dosages, although further validation with larger cohorts is needed. In practice, a simplified workflow without PCR amplification reduces the risk of contamination, technologist hands-on time, and overall cost, making noninvasive prenatal testing by shotgun sequencing more accessible to patients. The 22 autosomes were sorted with increasing overall GC content (chromosome 4 has the lowest and chromosome 19 has the highest GC content). At all total read numbers (2.5 million to 5 million), CVs showed a U-shaped distribution with high values at the 2 ends. Improvement in CVs was seen for most autosomes with the PCR Ϫ protocol. High CVs for chromosomes 20, 16, 17, 22, and 19 are also partially attributable to the small sizes of those chromosomes. Blue bars, PCR ϩ protocol; red bars, PCR Ϫ protocol.
Author Contributions: All authors confirmed they have contributed to the intellectual content of this paper and have met the following 3 requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; and (c) final approval of the published article.

Authors' Disclosures or Potential Conflicts of
Response Factor-Based Quantification for Mycophenolic Acid
To the Editor:
In contrast with chemistry or immunoassay analyzers, quantification for liquid chromatographytandem mass spectrometry (LC-MS/MS) 1 assays is mostly done by time-consuming multipoint calibration in each run (CR) (1 ). Few reports on alternative quantification methods have been published, with most of them being impractical for clinical purposes (1-3 ) and none of them covering a large period of time (1-4) . We evaluated the performance of quantification based on an experimentally derived response factor (RF) used for 1 year without change (4 ) for mycophenolic acid (MPA) compared to CR. We also examined the variables influencing RF quantification performance.
MPA was extracted by protein precipitation using a reagent containing deuterated internal standard (IS) and analyzed on an Alliance HPLC 2795 separations module coupled to a Quattro Micro tandem MS (both Waters Corp.). From June 2012 to May 2013, the first 10 patient samples, QCs of each run, and external QCs were quantified by CR and RF. CR was performed using a weighted (1/x) linear regression of 7 calibrators. RF quantification was performed by multiplying the observed response ratio (RR) (area analyte/area IS) by an RF, determined as the slope of a linear regression model, which plotted the theoretical concentration MPA as a function of the RR (data from the interassay variability experiment). Both methods were analytically validated, and no substantial difference between RF and CR quantification was observed.
Of the 2170 patient samples quantified by CR and RF, 193 (8.9%) showed a difference Ն15%. The majority of the differences (171/193) occurred during the period of January 15, 2013, to February 6, 2013. In the first run of this period, a sudden and major decrease (Ϫ33.5%) of IS area with a stable MPA area (2.7%) was observed for QCs. This occurred together with the introduction of a new lot of IS solution, pointing to a bad preparation of the new lot (Fig.  1) . As pipette control results were fine, this was probably due to human error. For the remaining 22 samples with a difference Ն15%, most had a concentration Յ0.4 mg/L. At these low concentrations, small absolute differences yield large relative differences. Deuterated MPA was used as IS at concentration near the middle of the reported therapeutic reference interval (1.0 -3.0 mg/L) (3 ). There was no effect of the distance from the optimal RR (1.0) on the difference between RF and CR quantification. For 85 of 2170 (3.9%) samples, a discordant clinical classification would have been made using the 1.0 -3.0 mg/L reference interval. Most often this was caused by minor absolute differences (Յ0.2 mg/L) (43/85), likely not causing substantial changes in clinical management. More striking differences were noticed in the period using the bad IS solution (31/85). External QC
